Journal of Cancer Immunology & Therapy

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

About The Journal Open Access

Journal of Cancer Immunology & Therapy

The journal welcomes submissions from all related fields to the Cancer Immunology & Therapy which utilises the immune system as a treatment for cancer. Cancer immunology is an interdisciplinary branch of biology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well-known application is cancer immunotherapy.

Aims and Scope

Journal of Cancer Immunology & Therapy is a peer-reviewed, open access journal that reflects articles on all types of tumor immunology. The journal serves as a forum for new concepts and advances in basic Cancer Discovery, Cancer Epidemiology, Biomarkers & Prevention, Cancer Immunology Research, Cancer Surgery, Advances in Cancer Prevention, Breast Cancer, Cancer Biology, Cancer Treatment, Cancer Management and Research, Integrative Cancer Therapies, Clinical cancer immunology and therapy.

Journal of Cancer Immunology & Therapy organize a new platform for the researchers, scientists, scholars, students in this field to publish their research work & update the latest research information to the scientific community. Chief criteria for acceptance are scientific novelty and quality, originality, clarity, and conciseness with early online publication, regular podcasts and an immense archive collection.

You may submit manuscripts as an email attachment to the e-mail id [email protected] 

Please submit your manuscript to
[email protected]

Just Published Articles View More

Review Article February 28, 2019

P.35-41

J Cancer Immunol Ther: 2(1): 35-41

Irreversible electroporation of renal tumours: A review and an update.

Anthony Kodzo-Grey Venyo*

Short Communication February 26, 2019

P.31-34

J Cancer Immunol Ther: 2(1): 31-34

Sweat gland or hair follicle? - Eccrine spiradenoma.

Anubha Bajaj*

Research Article February 12, 2019

P.19-30

J Cancer Immunol Ther: 2(1): 19-30

Biomineralogy of lung tumors.

Maciej Pawlikowski*

Research Article January 22, 2019

P.7-18

J Cancer Immunol Ther: 2(1): 7-18

Primary leiomyosarcoma of the adrenal gland: A review and update of literature.

Anthony Kodzo-Grey Venyo

Research Article January 07, 2019

P.4-6

J Cancer Immunol Ther: 2(1): 4-6

A phase-2 study of high-dose pineal antitumor hormone Melatonin as an adjuvant therapy in triple negative breast cancer.

Paolo Lissoni*, Franco Rovelli, Giusy Messina, Vezika Cenaj, Giorgio Porro, Giuseppe Di Fede

Case Report January 02, 2019

P.1-3

J Cancer Immunol Ther: 2(1): 1-3

Nocardiosis in cancer patients

Parijat N Goswami, Harsha Panchal, Sonia Parikh, Hitesh Rajpara, Hemang Purohit